Search results
27 kwi 2023 · When cervical cancer is diagnosed at an early stage, the 5-year relative survival rate is 91%. When cervical cancer is diagnosed after it has spread to nearby tissues, organs, or regional lymph nodes, the 5-year relative survival rate is 60%.
- Childhood Cervical & Vaginal Cancers
Childhood cervical and vaginal cancers are very rare types...
- Causes, Risk Factors, & Prevention
Cervical cancer screening may be more difficult in those...
- Research
NCI is the nation’s leader in cancer research. Learn about...
- Diagnosis
If you have symptoms or screening test results that suggest...
- Screening
Cervical cancer screening saves lives. Very few people...
- Symptoms
These symptoms may be caused by many conditions other than...
- Relative Survival Rate
NCI's Dictionary of Cancer Terms provides easy-to-understand...
- HIV
NCI's Dictionary of Cancer Terms provides easy-to-understand...
- Childhood Cervical & Vaginal Cancers
14 gru 2022 · Cervical cancer incidence was high in Malawi (67·9 [65·7–70·1]) and Zambia (65·5 [63·0–67·9]) in Africa, Bolivia (36·6 [35·0–38·2]) and Paraguay (34·1 [32·1–36·1]) in Latin America, Maldives (24·5 [17·0–32·0]) and Indonesia (24·4 [24·2– 24·7]) in Asia, and in Fiji (29·8 [24·7–35·0]) and Papua New Guinea (29·2 ...
5 mar 2024 · Cervical cancer is the fourth most common cancer in women globally with around 660 000 new cases and around 350 000 deaths in 2022. The highest rates of cervical cancer incidence and mortality are in low- and middle-income countries.
4 kwi 2024 · Cervical cancer is the fourth most common cancer in terms of both incidence and mortality in women (Figure 3C), with an estimated 660,000 new cases and 350,000 deaths worldwide in 2022 (Table 1).
The earlier cervical cancer is caught, the better chance a person has of surviving five years after being diagnosed. For cervical cancer, 42.0% are diagnosed at the local stage. The 5-year relative survival for localized cervical cancer is 91.1%.
4 dni temu · The INTERLACE trial was a multicentre, randomised phase 3 trial done at 32 medical centres in Brazil, India, Italy, Mexico, and the UK. Adults (aged ≥18 years) with locally advanced cervical cancer (FIGO 2008 stage IB1 disease with nodal involvement, or stage IB2, IIA, IIB, IIIB, or IVA disease) were randomly assigned (1:1), by minimisation, using a central electronic system, to standard ...
4 gru 2019 · Cervical cancer kills approximately 300 000 women and affects nearly 600 000 women yearly, particularly middle-aged women and those living in lower-resource settings. However, most cervical cancers and related deaths can be avoided by integrated HPV-based screening and vaccination.
